Contact this trialFirst, we need to learn more about you.
Peptide
Larazotide for Long COVID
Recruiting0 awardsPhase 2
Boston, Massachusetts
This trial is testing Larazotide, an oral medication, in young individuals with Long COVID symptoms. The medication aims to strengthen the gut barrier to help reduce these symptoms.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service